BAJAJ BROKING

Notification close image
No new Notification messages
card image
Seshaasai Technologies Ltd IPO
Apply for the Seshaasai Technologies Ltd IPO through UPI in Just minutes
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

How to Apply for the Curis Lifesciences IPO: Step-by-Step Investment Guide

Curis Lifesciences Limited is a pharmaceutical manufacturer engaged in the development, production, and distribution of a diverse range of medicines. Established in 2010, the company operates in both domestic and international markets, offering products such as tablets, capsules, oral liquids, external preparations, and sterile ophthalmic ointments. It has a strong client base through loan licence and contract manufacturing, along with its own brand marketing operations in select overseas markets. The company’s manufacturing facility in Gujarat follows strict quality control measures and regulatory standards, which help maintain the efficacy and safety of its products. With steady financial growth and a presence in multiple therapeutic segments, Curis Lifesciences continues to strengthen its position in the pharmaceutical manufacturing space.

Investors can apply for the Curis Lifesciences IPO through their bank’s net banking facility using the ASBA (Application Supported by Blocked Amount) process or via stockbroking platforms such as Zerodha, Upstox, Angel One, or Groww. To apply, log in to your preferred platform, choose the IPO section, select “Curis Lifesciences Limited,” enter the number of lots, confirm the bid price, and submit the application. Upon successful submission, the bid amount will be blocked in your linked bank account until the IPO allotment process is completed

For more details, visit the Curis Lifesciences IPO page.

Curis Lifesciences IPO Details and Objectives

Details

Information

IPO Date

November 7, 2025 to November 11, 2025

Issue Size

21,50,000 shares

(aggregating up to ₹27.52 Cr)

Price Band

₹120 to ₹128 per share

Lot Size

1000 shares

Listing At

SME NSE

Market Maker

RS Wealth Management Private Limited

Purpose of the IPO

  • Capital Expenditure towards Upgradation/Improvement of the existing Manufacturing Facilities

  • Capital Expenditure towards Construction of a Storage Facility

  • Pre-payment/Repayment of outstanding Secured Loans

  • Product Registrations in other countries

  • Funding our Working Capital Requirements

  • General Corporate Purposes

Timeline of Curis Lifesciences IPO

Event

Date

IPO Open Date

Fri, Nov 7, 2025

IPO Close Date

Tue, Nov 11, 2025

Tentative Allotment

Wed, Nov 12, 2025

Initiation of Refunds

Thu, Nov 13, 2025

Credit of Shares to Demat

Thu, Nov 13, 2025

Tentative Listing Date

Fri, Nov 14, 2025

Cut-off time for UPI mandate confirmation

5 PM on Tue, Nov 11, 2025

Pricing & Lot Size of Curis Lifesciences IPO

Price Band for the IPO

  •  ₹120 to ₹128 per share

Minimum Lot Size and Application Details

Application

Lots

Shares

Amount

Individual investors (Retail) (Min)

2

2,000

₹2,56,000

Individual investors (Retail) (Max)

2

2,000

₹2,56,000

S-HNI (Min)

3

3,000

₹3,84,000

S-HNI (Max)

7

7,000

₹8,96,000

B-HNI (Min)

8

8,000

₹10,24,000

Curis Lifesciences IPO Application Process

The Curis Lifesciences IPO application process can be completed online through your trading platform. Below is a step-by-step guide to applying for the IPO:

Step 1: Login to Your Trading Platform

Access your trading account using the broker's app or website.

Step 2: Navigate to the IPO Section

Go to the IPO section to view active IPO listings.

Step 3: Select the Open IPO and Click Apply

Locate Curis Lifesciences IPO in the list of available IPOs and click the ‘Apply’ button.

Step 4: Enter the Quantity of Shares You Wish to Apply For

Specify the number of shares (minimum lot size: 1000 shares) within the price band of ₹120 to ₹128 per share.

Step 5: Provide Your UPI ID

Enter your UPI ID for payment authorization and ensure sufficient funds in your bank account.

Step 6: Confirm the Application

Review your application details and confirm the UPI mandate before 5 PM on the last application day.

Step 7: Complete the Process and Wait for Allotment

Submit the application and monitor the allotment status to check if shares have been allocated to you.

Financial Health and Performance

Key Financial Metrics

  • Total Assets: Grew from ₹29.75 crore in FY23 to ₹56.29 crore as of July 2025.

  • Total income: Reached ₹19.51 crore in FY25.

  • Profit After Tax (PAT): Stood at ₹2.87 crore for July 2025.

  • Net Worth: Recorded at ₹19.10 crore in FY25.

  • Reserves and Surplus: Recorded at ₹13.16 crore (July 2025), growing steadily over the years.

  • EBITDA: Stood at ₹4.24 crore in July 2025.

Recent Performance and Growth Prospects

  • The company has shown steady expansion in its asset base, reflecting consistent business growth and efficient resource management.

  • Its total income has witnessed an upward trend, indicating sustained demand for its products and stable operational performance.

  • Profit levels have remained healthy, suggesting improved cost management and operational efficiency.

  • The company’s net worth has strengthened, supported by a rise in retained earnings and reserves over time.

  • Reserves and surplus have grown steadily, showcasing financial stability and prudent management practices.

  • The company’s earnings before interest, tax, depreciation, and amortisation (EBITDA) indicate a sound operating performance and a strong foundation for future scalability.

  • Overall, Curis Lifesciences Limited reflects a pattern of consistent growth and improving financial strength, positioning it for further expansion in the coming years.

Investment Risks and Opportunities

Potential Risks of Investing in the IPO

  • The company’s operations depend significantly on third-party clients for contract and loan licence manufacturing, which may lead to fluctuations in demand and revenue.

  • Any delays in regulatory approvals, changes in compliance norms, or quality-related issues could affect manufacturing timelines and overall business performance.

Opportunities and Growth Potential

  • With the planned utilisation of IPO proceeds for facility upgrades, new storage construction, and product registrations in other countries, the company aims to enhance its production capabilities and expand its market presence.

  • Increasing global and domestic demand for pharmaceutical formulations, coupled with the company’s focus on diversification and compliance-driven growth, may support long-term business sustainability.

Key Performance Indicator (KPI)

KPI

Values

ROE

55.25%

ROCE

27.83%

Debt/Equity

0.96

RoNW

37.62%

PAT Margin

12.43%

EBITDA Margin

19.41%

Price to Book Value

12.64

Market Capitalization

103.48

Curis Lifesciences IPO Registrar & Lead Managers

Registrar

Lead Manager(s)

MUFG Intime India Pvt.Ltd.

Finaax Capital Advisors Private Limited

Company Address of Curis Lifesciences Ltd

Curis Lifesciences Ltd. PF-23, GIDC Sanand - II, Industrial Estate, Sanand Ahmedabad, Gujarat, 382110

Phone: +91 99045 22543

Email: cs@curisls.com

Website: https://curisls.com/

Conclusion

Curis Lifesciences Limited operates in the pharmaceutical manufacturing space, offering a range of formulations across domestic and international markets. The company’s operations are diversified through loan licence manufacturing, contract production, and its own brand marketing, supported by a compliant manufacturing facility in Gujarat. Its financial records reflect consistent business activity and controlled operational practices.

The IPO aims to generate funds for facility improvements, storage infrastructure, loan repayment, and product registration in new markets. With defined objectives and a structured financial approach, the offering represents a part of the company’s plan to strengthen its operational base and maintain stability within the sector.

Interested in more opportunities? Check out our Upcoming IPO section for new listings and don’t forget to check your Curis Lifesciences IPO allotment status.

Frequently Asked Questions

No result found

search icon

Read More Blogs

Disclaimer :

The information on this website is provided on "AS IS" basis. Bajaj Broking (BFSL) does not warrant the accuracy of the information given herein, either expressly or impliedly, for any particular purpose and expressly disclaims any warranties of merchantability or suitability for any particular purpose. While BFSL strives to ensure accuracy, it does not guarantee the completeness, reliability, or timeliness of the information. Users are advised to independently verify details and stay updated with any changes. The securities are quoted as an example and not as a recommendation. Past performance is not necessarily a guide to future performance.

The information provided on this website is for general informational purposes only and is subject to change without prior notice. BFSL shall not be responsible for any consequences arising from reliance on the information provided herein and shall not be held responsible for all or any actions that may subsequently result in any loss, damage and or liability. Interest rates, fees, and charges etc., are revised from time to time, for the latest details please refer to our Pricing page.

Neither the information, nor any opinion contained in this website constitutes a solicitation or offer by BFSL or its affiliates to buy or sell any securities, futures, options or other financial instruments or provide any investment advice or service.

BFSL is acting as distributor for non-broking products/ services such as IPO, Mutual Fund, Insurance, PMS, and NPS. These are not Exchange Traded Products. For more details on risk factors, terms and conditions please read the sales brochure carefully before investing.

Investments in the securities market are subject to market risk, read all related documents carefully before investing. This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.

[ Read More ]

For more disclaimer, check here : https://www.bajajbroking.in/disclaimer

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

11 lakh+ Users

icon-with-text

4.6 App Rating

icon-with-text

4 Languages

icon-with-text

₹6,800+ Cr MTF Book

icon-with-text
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|